Drs. Gao, Krans, and Jarlenski found in their recent study that female parents are less likely to be diagnosed with a substance use disorder (SUD) or receive medication for an opioid use disorder (MOUD) than male parents. Removing policies that criminalize parental SUD and addressing childcare-related barriers may improve SUD identification and treatment.
Read more about their findings here: https://pubmed.ncbi.nlm.nih.gov/37214425/
Alice Gao, Dr. Liz Krans, and Dr. Marian Jarlenski found that later diagnosis of opioid use disorder (OUD) in pregnancy among non-White/Hispanic women partially explains the disparities in medication for opioid use disorder (MOUD) receipt in this population. Universal substance use screening earlier in pregnancy, combined with connecting patients to evidence-based and culturally competent care, is an approach that could close the observed racial-ethnic disparity in MOUD receipt.
